Annexon (ANNX) Tax Provisions (2019 - 2020)
Annexon (ANNX) posted quarterly Tax Provisions of $10000.0 for Q4 2020, up 225.0% year-over-year from $3076.9 in Q1 2020, and up 900.0% quarter-over-quarter from $1000.0 in Q3 2020.
Powered by 
Analysis
Annexon (ANNX) Tax Provisions (2019 - 2020) Analysis & Trends
Annexon's Tax Provisions history runs 2 years deep, the most recent figure standing at $10000.0 for Q4 2020.
- In Q4 2020, Tax Provisions rose 225.0% year-over-year to $10000.0; the TTM figure through Dec 2020 stood at $7000.0 (changed N/A YoY), while the FY2020 annual figure was $15000.0, up 400.0% from the prior year.
- Tax Provisions for Q4 2020 stood at $10000.0, up from $1000.0 in the prior quarter.
- The five-year high for Tax Provisions was $10000.0 in Q4 2020, with the low at -$8000.0 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Annexon | 976.88 Mn | 976.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -13.32 Mn |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Dec 31, 2019 | -7.81 Mn |
| Sep 30, 2019 | 2,000.00 |